IRadimed
IRMD
#5584
Rank
A$1.81 B
Marketcap
A$142.84
Share price
-2.25%
Change (1 day)
65.95%
Change (1 year)
Categories

Earnings for IRadimed (IRMD)

Earnings in 2025 (TTM): A$41.9 Million

According to IRadimed's latest financial reports the company's current earnings are A$80.51 Million. In 2024 the company made an earning of A$34.32 Million, an increase over its 2023 earnings that were of A$30.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IRadimed from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$41.9 M22.09%
2024 A$34.32 M11.67%
2023 A$30.73 M34.35%
2022 A$22.87 M64.5%
2021 A$13.9 M-1694.53%
2020 -A$0.88 Million-106.82%
2019 A$12.78 M45.92%
2018 A$8.76 M343.81%
2017 A$1.97 M-87.25%
2016 A$15.48 M-5.86%
2015 A$16.44 M285.59%
2014 A$4.26 M8.39%
2013 A$3.93 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Edwards Lifesciences
EW
A$2.41 B 6,242.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
A$86.13 M 126.36%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.38 B 3,533.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
-A$31.11 Million-181.74%๐Ÿ‡บ๐Ÿ‡ธ USA